Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michal Pešta

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Metrika|June 26, 2023
Real-time changepoint detection in a nonlinear expectile modelGabriela Ciuperca, Matúš Maciak, Michal Pešta
International Journal of Molecular Sciences|October 11, 2017
Prediction Potential of Serum miR-155 and miR-24 for Relapsing Early Breast CancerPetra Bašová, Michal Pešta, Marek Sochor, et al.
Acta Chirurgiae Orthopaedicae Et Traumatologiae Cechoslovaca|March 27, 2025
[The Outcomes of Navicular Fracture Surgery]Marek Peml, Karel Holub, Martin Pompach, et al.
International Journal of Molecular Sciences|October 18, 2017
Plasma miR-155, miR-203, and miR-205 are Biomarkers for Monitoring of Primary Cutaneous T-Cell LymphomasNina Dusílková, Petra Bašová, Jindřich Polívka, et al.
Blood Cancer Journal|July 7, 2022
G-CSF plus azacitidine versus azacitidine alone for patients with high-risk myelodysplastic syndrome: academic, open label, randomized trialTomáš Stopka, Lubomír Minařík, Nina Dusilková, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Metrika|June 26, 2023
Real-time changepoint detection in a nonlinear expectile modelGabriela Ciuperca, Matúš Maciak, Michal Pešta
International Journal of Molecular Sciences|October 11, 2017
Prediction Potential of Serum miR-155 and miR-24 for Relapsing Early Breast CancerPetra Bašová, Michal Pešta, Marek Sochor, et al.
Acta Chirurgiae Orthopaedicae Et Traumatologiae Cechoslovaca|March 27, 2025
[The Outcomes of Navicular Fracture Surgery]Marek Peml, Karel Holub, Martin Pompach, et al.
International Journal of Molecular Sciences|October 18, 2017
Plasma miR-155, miR-203, and miR-205 are Biomarkers for Monitoring of Primary Cutaneous T-Cell LymphomasNina Dusílková, Petra Bašová, Jindřich Polívka, et al.
Blood Cancer Journal|July 7, 2022
G-CSF plus azacitidine versus azacitidine alone for patients with high-risk myelodysplastic syndrome: academic, open label, randomized trialTomáš Stopka, Lubomír Minařík, Nina Dusilková, et al.
Pageof 1